CITIUS PHARMACEUTICALS INC (CTXR) Stock Balance Sheet
NASDAQ:CTXR • US17322U3068
Current stock price
0.8487 USD
-0.05 (-5.7%)
Last:
| MRQ (2025-12-31) | 2025 (2025-9-30) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 7.72M | 4.25M | 3.25M | 26.48M | 41.70M | |||
| Receivables | 4.05M | N/A | N/A | N/A | N/A | |||
| Inventories | 22.64M | 22.29M | 8.27M | N/A | N/A | |||
| Other Current Assets | 3.54M | 1.40M | 2.70M | 7.89M | 2.90M | |||
| Total Current Assets | 37.95M | 27.93M | 14.22M | 34.37M | 44.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 835.20K | 818.70K | 246.30K | 455.90K | 700.00K | |||
| Goodwill | 9.35M | 9.35M | 9.35M | 9.35M | 9.30M | |||
| Intangibles | 92.23M | 92.80M | 92.80M | 59.40M | 59.40M | |||
| Other Non-Current Assets | 38.10K | 38.10K | 38.10K | 38.10K | 0.00 | |||
| Total Non-Current Assets | 102.45M | 103.00M | 102.43M | 69.24M | 69.40M | |||
| TOTAL ASSETS | 140.39M | 130.94M | 116.65M | 103.61M | 114.00M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 1.00M | 1.00M | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 7.94M | 7.57M | 2.49M | 2.85M | 3.40M | |||
| Accounts Payable | 11.02M | 13.69M | 4.93M | 2.93M | 1.20M | |||
| Other Current Liabilities | 18.25M | 22.65M | 28.40M | N/A | N/A | |||
| Total Current Liabilities | 38.21M | 44.91M | 35.81M | 5.78M | 4.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | 8.04M | 7.77M | 6.71M | 6.14M | 5.60M | |||
| Other Non-Current Liabilities | 681.60K | 724.90K | 21.30K | 262.90K | 500.00K | |||
| Total Non-Current Liabilities | 22.23M | 18.47M | 10.76M | 7.00M | 6.70M | |||
| TOTAL LIABILITIES | 60.43M | 63.39M | 46.57M | 12.78M | 11.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -247.02M | -238.80M | -201.37M | -162.23M | -129.70M | |||
| Additional Paid In Capital | 326.96M | 306.34M | 271.44M | 252.90M | 232.40M | |||
| Minority Interest | 13.51M | 9.98M | 4.02M | 600.40K | 600.00K | |||
| Common Shares | 22.40K | 18.10K | 7.30K | 158.90K | 100.00K | |||
| Shares Outstanding | 22.38M | 18.07M | 7.25M | 6.35M | 146.20M | |||
| Tangible Book Value per Share | -0.97 | -1.91 | -4.42 | 3.48 | 0.23 | |||
| Total Shareholders' Equity | 79.96M | 67.55M | 70.08M | 90.83M | 102.80M | |||
| TOTAL LIABILITIES AND EQUITY | 140.39M | 130.94M | 116.65M | 103.61M | 114.00M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 0.99 | 0.62 | 0.40 | 5.95 | 9.91 | |||
| Return On Assets (ROA) | -25.56% | -28.59% | -34.45% | -32.52% | -29.51% | |||
| Return On Equity (ROE) | -44.88% | -55.42% | -57.35% | -37.10% | -32.72% | |||
All data in USD , ROIC based on taxRate of 0.21